Insider Transaction Report for Pulse Biosciences, Inc.

Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences, Inc., reported the acquisition of 1036 shares of common stock on August 26, 2026, for a price of $48.235 per share. This was followed by the acquisition of an additional 1034 shares on August 28, 2026, at a price of $48.35 per share. All transactions were executed as open market purchases during a permitted trading window under the company's insider trading policy. Following these transactions, Ms. Teplitsky holds a total of 2070 shares. The reporting person has indicated that fractional shares were rounded down and that multiple transactions at the same price on a given day were consolidated for reporting purposes.